Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation

Transplant International

Volumn 23, Issue 4, 2010, Pages 382-389

  Doesch, Andreas O ^a   Ammon, Kerstin ^a   Konstandin, Mathias ^a   Celik, Sultan ^a   Kristen, Arnt ^a   Frankenstein, Lutz ^a   Müller, Susanne ^a   Sack, Falk Udo ^a   Katus, Hugo A ^a   Dengler, Thomas J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Heart transplantation; Infectious disease; Outcome; Toxoplasma gondii

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PYRIMETHAMINE; RAPAMYCIN; STATIN; STEROID; SULFAMETHOXAZOLE; TACROLIMUS; GAMMA INTERFERON; INTERLEUKIN 12;

ADULT; ARTICLE; CAUSE OF DEATH; CYTOMEGALOVIRUS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEROCONVERSION; TOXOPLASMA GONDII; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; METABOLISM; MIDDLE AGED; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INTERFERON-GAMMA; INTERLEUKIN-12; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME;

EID: 77649251150     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00993.x     Document Type: Article

References (6)

1. Arora S, Jenum PA, Aukrust P, et al. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol 2007 50 : 1967.
2. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis J. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 2008 85 : 980.
3. Scharton-Kersten TM, Wynn TA, Denkers EY, et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 1996 157 : 4045.
4. Koh KP, Wang Y, Yi T, et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest 2004 114 : 846.
5. Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998 120 : 87.
6. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998 17 : 744.